Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from FendX Technologies, Inc. ( (TSE:FNDX) ) is now available.
FendX Technologies has shifted its product strategy to prioritize a new liquid surface coating developed with McMaster University that has shown strong effectiveness against MRSA and P. aeruginosa and appears easier and cheaper to scale for long-lasting protection. As part of this pivot, the company has discontinued further development of its REPELWRAP film, terminated related license agreements with McMaster, and removed future licensing payment obligations while maintaining a collaborative relationship with the university.
The company is also advancing a specialized antimicrobial coating for Foley catheters, supported by extended research terms with McMaster and reduced payment commitments, and plans third-party testing to further validate performance. In parallel, FendX is building an AI-driven mobile app for real-time surface contamination detection and collaborating with Aquaox LLC on eco-friendly antimicrobial agents, moves that broaden its product pipeline and position it to offer integrated physical and digital hygiene solutions across consumer, commercial and healthcare markets.
More about FendX Technologies, Inc.
FendX Technologies Inc. is a surface protection company focused on developing technology-based solutions to reduce the spread of harmful pathogens in everyday environments. The company’s portfolio spans protective surface coatings and emerging digital tools, targeting applications in healthcare, consumer, commercial and other high-touch settings where hygiene and pathogen control are critical.
Average Trading Volume: 7,056
Technical Sentiment Signal: Sell
Current Market Cap: C$3.33M
Learn more about FNDX stock on TipRanks’ Stock Analysis page.